<SEC-DOCUMENT>0001171843-25-002849.txt : 20250507
<SEC-HEADER>0001171843-25-002849.hdr.sgml : 20250507
<ACCEPTANCE-DATETIME>20250507070013
ACCESSION NUMBER:		0001171843-25-002849
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250507
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250507
DATE AS OF CHANGE:		20250507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEVA PHARMACEUTICAL INDUSTRIES LTD
		CENTRAL INDEX KEY:			0000818686
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16174
		FILM NUMBER:		25919203

	BUSINESS ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
		BUSINESS PHONE:		972 (3) 914-8213

	MAIL ADDRESS:	
		STREET 1:		TEVA PHARMACEUTICAL INDUSTRIES LIMITED
		STREET 2:		124 DVORA HANEVI'A ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6944020
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_050725.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023"><head><title>Form 8-K</title></head><body style="font-size: 10pt"><div style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="Form8K" id="ixv-139">0000818686</ix:nonNumeric> <ix:nonNumeric format="ixt:booleanfalse" name="dei:AmendmentFlag" contextRef="Form8K" id="ixv-140">False</ix:nonNumeric></ix:hidden><ix:references> <link:schemaRef xlink:href="gnw-20190101.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="Form8K"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000818686</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-07</xbrli:startDate> <xbrli:endDate>2025-05-07</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> </ix:resources></ix:header></div><div style="margin-top: 3pt; margin-bottom: 12pt;"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%;">&#160;</div></div><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 0pt;">UNITED STATES</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">SECURITIES AND EXCHANGE COMMISSION</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">Washington, D.C. 20549</p><p style="text-align: center;">_________________</p><p style="font-size: 14pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="Form8K" id="ixv-160">8-K</ix:nonNumeric></p><p style="text-align: center;">_________________</p><p style="font-size: 12pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">CURRENT REPORT</p><p style="font-size: 12pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">Pursuant to Section 13 or 15(d)<br/>of the Securities Exchange Act of 1934</p><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 6pt; margin-bottom: 6pt;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" contextRef="Form8K" id="ixv-161">May 7, 2025</ix:nonNumeric></p><p style="text-align: center;">_______________________________</p><p style="font-size: 12pt; text-align: center; margin-top: 6pt; margin-bottom: 0; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="Form8K" id="ixv-162">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0; margin-bottom: 6pt;">(Exact name of registrant as specified in its charter)</p><p style="text-align: center;">_______________________________</p><table style="width: 100%; margin-right: auto; margin-left: auto;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 33%; font-size: 10pt; font-weight: bold; text-align: center;"><ix:nonNumeric format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" contextRef="Form8K" id="ixv-163">Israel</ix:nonNumeric></td><td style="width: 34%; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="Form8K" id="ixv-164">001-16174</ix:nonNumeric></td><td style="width: 33%; font-size: 10pt; font-weight: bold; text-align: center;"><!--<ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="Form8K">00-0000000</ix:nonNumeric>-->Not Applicable</td></tr><tr style="vertical-align: top;"><td style="font-size: 10pt; text-align: center;">(State or other jurisdiction of Incorporation)</td><td style="font-size: 10pt; text-align: center;">(Commission File Number)</td><td style="font-size: 10pt; text-align: center;">(IRS Employer Identification Number)</td></tr></table><!-- Postal Address Country= --><p style="font-size: 10pt; text-align: center; margin-top: 12pt; margin-bottom: 0pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="Form8K" id="ixv-165">124 Dvora Hanevi&#8217;a Street</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="Form8K" id="ixv-166">Tel Aviv</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="Form8K" id="ixv-167">6944020</ix:nonNumeric>, <ix:nonNumeric format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" contextRef="Form8K" id="ixv-168">Israel</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">(Address of Principal Executive Offices, including Zip Code)</p><!-- Phone Number --><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="Form8K" id="ixv-169">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="Form8K" id="ixv-170">3-914-8213</ix:nonNumeric></p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 6pt;">(Registrant's Telephone Number, including Area Code)</p><!-- Former Name --><p style="font-size: 10pt; font-weight: bold; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">Not Applicable</p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt;">(Former Name or Former Address, if Changed Since Last Report)</p><p style="text-align: center;">_______________________________</p><!-- Checkboxes --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><table style="width: 100%; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" contextRef="Form8K" id="ixv-171">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" contextRef="Form8K" id="ixv-172">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" contextRef="Form8K" id="ixv-173">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr><tr style="vertical-align: top;"><td style="width: 3%; text-align: center; vertical-align: middle;"><ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" contextRef="Form8K" id="ixv-174">&#9744;</ix:nonNumeric></td><td style="width: 97%; text-align: left;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table><!-- Securities Table --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Securities registered pursuant to Section 12(b) of the Act:</p><div><table border="0" cellspacing="0" cellpadding="0" style="width: 100%"><tr style="vertical-align: top"><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 39%; border-bottom: Black 1pt solid">Title of each class</td><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 23%; border-bottom: Black 1pt solid">Trading Symbol(s)</td><td style="font-size: 10pt; text-align: center; margin-top: 6pt; margin-bottom: 6pt; width: 38%; border-bottom: Black 1pt solid">Name of each exchange on which registered</td></tr><tr style="vertical-align: top"><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" name="dei:Security12bTitle" id="ixv-175">American Depositary Shares, each representing one Ordinary Share</ix:nonNumeric></span></td><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" name="dei:TradingSymbol" id="ixv-176">TEVA</ix:nonNumeric></span></td><td style="font-size: 10pt; text-align: center"><span><ix:nonNumeric contextRef="Form8K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-177">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><!-- Emerging Growth Company --><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-size: 10pt; text-align: right; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">Emerging growth company <ix:nonNumeric format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" contextRef="Form8K" id="ixv-178">&#9744;</ix:nonNumeric></p><p style="font-size: 10pt; text-align: left; text-indent: 0; margin-top: 6pt; margin-bottom: 6pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 4pt solid;">&#160;</div><div style="page-break-before: always; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div><!-- 8-K Items --><div><div><div style="font-size: 10pt;"><strong>Item 2.02. Results of Operations and Financial Condition.</strong></div><div style="font-size: 10pt;"><p>On May 7, 2025, Teva Pharmaceutical Industries Ltd. issued a press release announcing its financial results for the period ended March 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and the information contained therein is incorporated herein by reference.&#160;</p><p>The information included in this Item 2.02 is being furnished to the Securities and Exchange Commission and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p></div></div><div><div style="font-size: 10pt;"><strong>Item 9.01. Financial Statements and Exhibits.</strong></div><div style="font-size: 10pt;"><p>(d) Exhibits</p><table style="font-size: 10pt;" border="0" cellspacing="0" cellpadding="0"><tr><td style="font-size: 10pt; font-weight: bold; text-decoration: underline;" valign="bottom">Exhibit No.</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt; font-weight: bold; text-decoration: underline;" valign="bottom">Description of Document</td></tr><tr><td style="font-size: 10pt;">&#160;</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;">&#160;</td></tr><tr><td style="font-size: 10pt;"><a href="exh_991.htm">99.1</a></td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;"><a href="exh_991.htm">Teva Reports 2025 First Quarter Financial Results</a></td></tr><tr><td style="font-size: 10pt;">104</td><td style="font-size: 10pt; width: 20px;">&#160;</td><td style="font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table></div></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 4pt solid;">&#160;</div><div style="page-break-before: always; margin-top: 0pt; margin-bottom: 0pt;">&#160;</div><!-- Signatures --><p style="font-size: 10pt; text-align: center; font-weight: bold;">SIGNATURES</p><p style="font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><table style="width: 100%;" border="0" cellspacing="0" cellpadding="0"><tr style="vertical-align: top;"><td>&#160;</td><td style="font-size: 10pt; font-weight: bold;" colspan="2">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</td></tr><tr style="vertical-align: top;"><td style="width: 49%;">&#160;</td><td style="width: 2%;">&#160;</td><td style="width: 49%;">&#160;</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;"/></tr><tr style="vertical-align: top;"><td style="font-size: 10pt;">Date: May 7, 2025</td><td style="font-size: 10pt;">By:&#160;</td><td style="text-decoration: underline; font-size: 10pt;">/s/ Eli Kalif&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;">Eli Kalif</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;">Executive Vice President, Chief Financial Officer</td></tr><tr style="vertical-align: top;"><td>&#160;</td><td>&#160;</td><td style="font-size: 10pt;"/></tr></table><!-- Exhibit Index --><div></div><!-- +972- 3-914-8213 Form 8-KMay 7, 2025 --><p>&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html lang="en-US">
<!-- Field: Set; Name: Tidy Processed; Value: True -->
<head>
  <title>EdgarFiling</title>
  <meta content="text/html; charset=windows-1252" >
  <meta name="GENERATOR" content="MSHTML 8.00.7601.18094" >
</head>
<body bgcolor="#ffffff">

<p style="text-align: right;"><strong>EXHIBIT 99.1</strong></p>

<p style="text-align: center;"><strong>Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing
~40%; 2025 Profit Outlook Improved</strong></p>

<p style="text-align: center;" ></p>

<p></p>

<p>For an accessible version of this Press Release, please visit www.tevapharm.com</p>

<ul type="disc">

<li style="margin-bottom:6pt;">On track for 30% operating profit margin by 2027 in line with our Pivot to Growth Strategy; Q1 2025 shows
ninth consecutive quarter of revenue growth, excluding revenues recorded for Sanofi collaboration.</li>

<li style="margin-bottom:6pt;">Q1 2025 revenues of $3.9 billion, an increase of 5%; net of $100 million foreign exchange impact, reported
revenues growth of 2%.</li>

<li style="margin-bottom:6pt;">AUSTEDO<sup>&#174;</sup> &#8211; shows continued strong growth, with worldwide revenues of $411 million
in Q1 2025, an increase of 39% in local currency terms compared to Q1 2024; increasing 2025 full-year revenue outlook from ~$1.9-2.05
billion to $1.95-2.05 billion.</li>

<li style="margin-bottom:6pt;">AJOVY<sup>&#174;</sup> &#8211; global revenues of $139 million in Q1 2025, an increase of 26% in local
currency terms compared to Q1 2024. Reaffirming $600M 2025 revenue outlook.</li>

<li style="margin-bottom:6pt;">UZEDY<sup>&#174;</sup> continues strong momentum &#8211; global revenues of $39 million in Q1 2025.</li>

<li style="margin-bottom:6pt;">The generics business grew across all regions &#8211; increased by 5% in the U.S., 1% in Europe and 2%
in International Markets, all in local currency terms, as compared to Q1 2024.</li></ul>

<ul type="disc">

<li style="margin-bottom:6pt;">Duvakitug (Anti-TL1A) Phase 3 ready; program initiation expected in H2 2025; preparing for olanzapine LAI
FDA NDA submission in H2 2025.</li>

<li style="margin-bottom:6pt;">Transforming Teva: Targeted programs to deliver~$700 million of net savings, after incremental reinvestment
behind growth, to transform Teva into a modern biopharmaceutical company and achieving 30% operating margin target in 2027.</li>

<li style="margin-bottom:6pt;">Current, confirmed U.S. tariffs expected to have immaterial impact; absorbed in updated 2025 non-GAAP outlook.</li>

<li style="margin-bottom:6pt;">Teva to host Innovation &amp; Strategy Day on Thursday, May 29 in New York, NY.</li></ul>

<p><strong>Q</strong><strong>1</strong><strong> 202</strong><strong>5</strong><strong> Highlights:</strong></p>

<ul type="disc">

<li style="margin-bottom:6pt;">Revenues of $3.9 billion</li>

<li style="margin-bottom:6pt;">GAAP diluted EPSof $0.18</li>

<li style="margin-bottom:6pt;">Non-GAAP diluted EPS of $0.52, an increase of $0.04 or 8% year-over-year</li>

<li style="margin-bottom:6pt;">Cash flow used in operating activities of $105 million</li>

<li style="margin-bottom:6pt;">Free cash flow of $107 million</li>

<li style="margin-bottom:6pt;">Underlying full-year outlook increased, excluding the impact of the Japan BV divestiture which closed on
March 31, 2025 full year 2025 business outlook<sup>(</sup><sup>1)(2)</sup>revised:<br >

<ul type="circle">

<li style="margin-bottom:6pt;">Revenues of $16.8 &#8208; $17.2 billion (-$200 million impact from at the high-end)</li>

<li style="margin-bottom:6pt;">Non&#8208;GAAP operating income of $4.3&#8208;$4.6 billion (+$200 million at the low-end; mid-point increased
by $100 million)</li>

<li style="margin-bottom:6pt;">Adjusted EBITDA of $4.7 &#8208; $5.0 billion(+$200 million at the low-end; same as above)&#160;&#160;</li>

<li style="margin-bottom:6pt;">Non&#8208;GAAP diluted EPS of $2.45 &#8208; $2.65 (+$0.10 at the low-end, mid-point increased by $0.10)</li>

<li style="margin-bottom:6pt;">Free cash flow of $1.6 &#8208;
$1.9 billion (unchanged)</li></ul> </li></ul>

<p>(1)&#160;Revised 2025 outlook now includes no contribution from the Japan BV after Q1 and continues to include a full year contribution
from Teva API, as well as exclude the expected income from development milestone payments from Sanofi in connection with the Phase 3 ulcerative
colitis and Crohn&#8217;s Disease initiations for duvakitug.</p>

<p>(2) This outlook is based on the existing tariff and trade environment as of May 7, 2025, and does not reflect any policy shifts, including
pharmaceutical sector tariffs, that could impact business.</p>

<p>TEL AVIV, May 07, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the
quarter ended March 31, 2025.</p>

<p>Mr. Richard Francis, Teva's President and CEO, said, &#8220;Teva had a solid start to the year, with its ninth consecutive quarter
of revenue growth, delivering global revenues of $3.9 billion, an increase of 5% in local currency terms compared to the first quarter
of 2024. Our key innovative growth drivers continue to show strong momentum, collectively generating revenues of $589 million while each
growing more than 25% year over year. We also achieved solid generics performance across all regions with biosimilars rounding out the
portfolio.&#8221;</p>

<p>Mr. Francis continued, &#8220;Now entering the Acceleration Phase of our Pivot to Growth Strategy, we have a clear roadmap to continue
Teva's transformation into a leading biopharmaceutical company with an expected 30% operating margin and today have announced ~$700 million
net savings by 2027. We&#8217;re accelerating innovative growth and strengthening our generics business, while streamlining our operations,
sharpening our business and optimizing processes. With these results, we are revising our 2025 outlook and reaffirming our 2027 targets.&#8221;</p>

<p><strong>Pivot to Growth Strategy</strong></p>

<p>In Q1 2025, we continued to execute on the four key pillars of our Pivot to Growth strategy, which we announced in May 2023.</p>

<ul type="disc">

<li style="margin-bottom:6pt;"><strong>Delivering on our Growth Engines -</strong> on the first pillar, we continued to demonstrate strong
performance of our key innovative products &#8211; AUSTEDO, AJOVY, and UZEDY. Collectively, these products grew ~39% year-over-year in
the first quarter. This growth is driven by the strength of their product profiles, continued investments to promote awareness and access,
and focused execution by our sales and marketing teams globally.</li>

<li style="margin-bottom:6pt;"><strong>Stepping Up Innovation</strong> - on the second pillar, we accelerated the development of certain
key pipeline assets, including the recent positive Phase 2b results for duvakitug (anti-TL1A) in Crohn&#8217;s Disease and ulcerative
colitis. We anticipate upcoming milestones for olanzapine LAI (NDA filing in 2025) and for DARI (Dual-action Asthma Rescue Inhaler; Phase
3 full enrollment in 2025 and potential Phase 3 event-driven read-out in 2026), as well the announcement of the start of the Phase 3 IBD
programs for duvakitug in H2 2025.</li>

<li style="margin-bottom:6pt;"><strong>Sustaining Our Generic</strong><strong>s</strong> <strong>Powerhouse</strong> - under the third
pillar, we remained focused on strengthening our position as a global leader in generic medicines with a streamlined portfolio, robust
pipeline, integrated manufacturing and global commercial footprint. In the past few quarters, we achieved several successful launches
of biosimilars and other high-value complex generics including liraglutide, octreotide, SIMLANDI<sup>&#174;</sup> (adalimumab-ryvk), SELARSDI<sup>TM</sup>
(ustekinumab-aekn) and Epysqli<sup>&#174;</sup>&#160;(eculizumab-aagh).</li>

<li style="margin-bottom:6pt;"><strong>Focusing</strong><strong> our Business</strong> - Lastly, on our fourth pillar, to accelerate our
growth we are actively transforming our business through portfolio and global manufacturing footprint optimization. Our ongoing efforts
to allocate capital appropriately include debt repayment of $1.4 billion at maturity, our recently completed divestment of our business
venture in Japan, our intention to divest our API business through a sale, and ongoing programs to improve working capital efficiency.</li>

<li style="margin-bottom:6pt;">Teva is moving into the second phase of our Pivot to Growth strategy &#8211; <strong>Acceleration</strong>.
We will focus on growing our innovative portfolio, modernizing and simplifying our organization and operations, reinforcing our commitment
to patents, and aligning capital allocation to invest in the highest value activities.</li></ul>

<ul type="disc">

<li style="margin-bottom:6pt;">Teva continues in its effort to sell its active-pharmaceutical ingredient (API) business and is engaged
with prospective purchasers. The timing and structure of the planned transaction are subject to ongoing consideration and the consummation
of the sale remains contingent on reaching a definitive agreement, subject to approval by Teva's Board of Directors. On December 31, 2024,
Teva classified its API business (including its R&amp;D, manufacturing and commercial activities) as held for sale.</li></ul>

<p><strong>First </strong><strong>Quarter 2025 Consolidated Results</strong></p>

<p><strong>Revenues</strong> in the first quarter of 2025 were $3,891 million, an increase of 2% in U.S. dollars or 5% in local currency
terms, compared to the first quarter of 2024. This increase was mainly due to higher revenues from AUSTEDO in our United States segment,
from generic products in all our segments, from AJOVY in all our segments, as well as from UZEDY in our U.S. segment, partially offset
by lower revenues from the sale of mature innovative product rights in 2024.<strong> Exchange rate</strong> movements during the first
quarter of 2025, including hedging effects, negatively impacted revenues by $101 million, compared to the first quarter of 2024.</p>

<p><strong>Exchange rate</strong> movements during the first quarter of 2025, including hedging effects, negatively impacted our operating
income by $50 million and non-GAAP operating income by $51 million compared to the first quarter of 2024.</p>

<p><strong>Gross profit</strong> in the first quarter of 2025 was $1,877 million, an increase of 6% compared to $1,771 million in the
first quarter of 2024. <strong>Gross profit margin</strong> was 48.2% in the first quarter of 2025, compared to 46.4% in the first quarter
of 2024. <strong>Non-GAAP gross profit</strong> was $2,054 million in the first quarter of 2025, an increase of 5% compared to $1,963
million in the first quarter of 2024. <strong>Non-GAAP gross profit margin</strong> was 52.8% in the first quarter of 2025, compared to
51.4% in the first quarter of 2024. The increase in both gross profit margin and non-GAAP gross profit margin was mainly due to a favorable
mix of products, primarily driven by higher revenues from AUSTEDO, partially offset by a negative impact from foreign exchange rate movements
including hedging effects.</p>

<p><strong>Research and Development (R&amp;D)</strong> <strong>expenses, net</strong> in the first quarter of 2025 were $247 million,
an increase of 2% compared to $242 million in the first quarter of 2024. Our higher R&amp;D expenses, net in the first quarter of 2025
compared to the first quarter of 2024, were mainly due to an increase in immunology and in immuno-oncology projects, as well as in our
late-stage innovative pipeline in neuroscience (mainly neuropsychiatry), partially offset by the non-recurrence of milestone payments
related to certain biosimilar projects in the first quarter of 2025.</p>

<p><strong>Selling and Marketing (S&amp;M) expenses</strong> in the first quarter of 2025 were $622 million, an increase of 2% compared
to the first quarter of 2024. This&#160;increase&#160;was&#160;mainly&#160;to&#160;support&#160;revenue&#160;growth<strong>.</strong></p>

<p><strong>General and Administrative (G&amp;A) expenses</strong> in the first quarter of 2025 were $297 million, an increase of 7% compared
to the first quarter of 2024.</p>

<p><strong>Other </strong><strong>loss </strong>in the first quarter of 2025 was $5 million, compared to $1 million in the first quarter
of 2024.</p>

<p><strong>Operating I</strong><strong>ncome</strong> in the first quarter of 2025 was $519 million, compared to an operating loss of
$218 million in the first quarter of 2024. Operating income as a percentage of revenues was 13.3% in the first quarter of 2025, compared
to an operating loss as a percentage of revenues of 5.7% in the first quarter of 2024. This increase was mainly due to other asset impairments,
restructuring and other items in the first quarter of 2024 as well as higher gross profit in the first quarter of 2025. <strong>N</strong><strong>on-GAAP
operating income</strong> in the first quarter of 2025 was $946 million representing a non-GAAP operating margin of 24.3% compared to
non-GAAP operating income of $892 million representing a non-GAAP operating margin of 23.4% in the first quarter of 2024. The increase
in non-GAAP operating margin in the first quarter of 2025 was due to higher gross profit margin, partially offset by an increase of operating
expenses as a percentage of revenues.</p>

<p><strong>Financial expenses, net</strong> in the first quarter of 2025, were $225 million, mainly comprised of net-interest expenses
of $212 million. In the first quarter of 2024, financial expenses, net were $250 million, mainly comprised of net-interest expenses of
$233 million.</p>

<p>In the first quarter of 2025, we recognized a<strong> tax expense</strong> of $74 million, on a pre-tax income of $294 million. In
the first quarter of 2024, we recognized a tax benefit of $52 million, on a pre-tax loss of $467 million.</p>

<p><strong>Non-GAAP</strong><strong> tax rate</strong> in the first quarter of 2025 was 17.5%, compared to 15.0% in the first quarter
of 2024. Our non-GAAP tax rate in the first quarter of 2025 was mainly affected by the generation of profits in various jurisdictions
in which tax rates are different than the Israeli tax rate as well as infrequent or non-recurring items. Our non-GAAP tax rate in the
first quarter of 2024 was mainly affected by deferred tax benefits resulting from IP-related integration plans, the generation of profits
in various jurisdictions with different tax rates, tax benefits in Israel and other countries, as well as infrequent or non-recurring
items.</p>

<p>We expect our annual non-GAAP tax rate for 2025 to be between 15%-18%, slightly higher than our non-GAAP tax rate for 2024, which was
15.3%, mainly due to net tax benefit related to deferred tax assets resulting from intellectual property-related integration plans in
2024.</p>

<p><strong>Net income </strong>attributable to Teva and <strong>diluted earning</strong><strong>s</strong><strong> per share </strong>in
the first quarter of 2025 were $214 million and $0.18, respectively, compared to net loss attributable to Teva and loss per share of $139
million and $0.12, respectively, in the first quarter of 2024. This change was mainly due to higher operating income in the first quarter
of 2025, partially offset by higher net loss attributable to redeemable and non-redeemable non-controlling interests in the first quarter
of 2024 as well as higher income taxes in the first quarter of 2025, as discussed above. <strong>Non-GAAP net income</strong> attributable
to Teva and <strong>non-GAAP diluted </strong><strong>earnings per share</strong> in the first quarter of 2025 were $602 million and $0.52,
respectively, compared to $548 million and $0.48, respectively, in the first quarter of 2024.</p>

<p><strong>Adjusted EBITDA</strong> was $1,041 million in the first quarter of 2025, an increase of 4%, compared to $1,005 million in
the first quarter of 2024.</p>

<p>As of March 31, 2025 and 2024, the <strong>fully diluted share count</strong> for purposes of calculating our market capitalization
was approximately 1,178 million shares and 1,167&#160;million shares, respectively.</p>

<p><strong>Non-GAAP information</strong>: net non-GAAP adjustments in the first quarter of 2025 were $388 million. Non-GAAP net income
attributable to Teva and non-GAAP diluted EPS for the first quarter of 2025 were adjusted to exclude the following items:</p>

<ul type="disc">

<li style="margin-bottom:6pt;">Amortization of purchased intangible assets of $145 million, of which $135 million is included in cost
of sales and the remaining $10 million in S&amp;M expenses;</li>

<li style="margin-bottom:6pt;">Impairment of long-lived assets in the amount of $77 million;</li>

<li style="margin-bottom:6pt;">Legal settlements and loss contingencies of $83 million;</li>

<li style="margin-bottom:6pt;">Contingent consideration expenses of $11 million;</li>

<li style="margin-bottom:6pt;">Equity compensation expenses of $34 million;</li>

<li style="margin-bottom:6pt;">Restructuring expenses of $14 million;</li>

<li style="margin-bottom:6pt;">Financial expenses of $14 million;</li>

<li style="margin-bottom:6pt;">Other non-GAAP items of $63 million;</li>

<li style="margin-bottom:6pt;">Items attributable to redeemable non-controlling interests of $2 million; and</li>

<li style="margin-bottom:6pt;">Corresponding tax effects and unusual tax items of $55 million;&#160;&#160;</li></ul>

<p>We believe that excluding such items facilitates investors&#8217; understanding of our business including underlying performance trends,
thereby improving the comparability of our business performance results between reporting periods.</p>

<p>For a reconciliation of the U.S. GAAP results to the adjusted non-GAAP figures and for additional information, see the tables below
and the information included under &#8220;Non-GAAP Financial Measures.&#8221; Investors should consider non-GAAP financial measures in
addition to, and not as replacement for, or superior to, measures of financial performance prepared in accordance with GAAP.</p>

<p><strong>Cash flow </strong><strong>used in operating activities</strong> during the first quarter of 2025 was $105 million, compared
to $124 million of cash flow used in operating activities in the first quarter of 2024. The lower cash flow used in operating activities
in the first quarter of 2025 resulted mainly from higher profit in our U.S. segment, partially offset by higher tax payments. Net changes
in working capital items were neutral.</p>

<p>During the first quarter of 2025, we generated <strong>free cash flow</strong> of $107 million, which we define as comprising $105
million in cash flow used in operating activities, $322 million in beneficial interest collected in exchange for securitized accounts
receivables (under our EU securitization program) and $17 million proceeds from divestitures of businesses and other assets, partially
offset by $127 million in cash used for capital investment. During the first quarter of 2024, we generated free cash flow of $32 million,
which we define as comprising $124 million in cash flow used in operating activities, $295 million in beneficial interest collected in
exchange for securitized accounts receivables (under our EU securitization program), partially offset by $124 million in cash used for
capital investment and $15 million in cash used for acquisition of businesses, net of cash acquired. The increase in 2025 resulted mainly
from higher proceeds from divestitures of businesses and other assets and lower cash used for acquisition of businesses, net of cash acquired,
as well as from lower cash flow used in operating activities.</p>

<p>As of March 31, 2025, our <strong>debt</strong> was $16,651 million, compared to $17,783 million as of December 31, 2024. This decrease
was mainly due to repayment at maturity of $1,368 million of our senior notes, partially offset by $233 million of exchange rate fluctuations.
The portion of total debt classified as short-term as of March 31, 2025 was 3% compared to 10% as of December 31, 2024.</p>

<p align="left">Our average debt maturity was approximately 5.7 years as of March 31, 2025, compared to 5.5
years as of December 31, 2024.</p>

<p><strong>Segment Results for the First Quarter of 2025</strong></p>

<p><strong>United States Segment</strong></p>

<p>The following table presents revenues, expenses and profit for our United States segment for the three months ended March 31, 2025
and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="max-width:34%; width:34%; min-width:34%;;vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:16%; width:16%; min-width:16%;;vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td colspan="6" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">
        <p class="hugin"><strong>Three months ended March 31,</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td colspan="3" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; text-align: center; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;"><strong>&#160;</strong></p>
        </td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td></tr>
  <tr>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td colspan="6" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions / % of Segment Revenues)</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Revenues</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td class="hugin">
        <p class="hugin">1,910</p> </td>
    <td class="hugin">
        <p class="hugin">100%</p> </td>
    <td class="hugin">
        <p class="hugin">$</p> </td>
    <td class="hugin">
        <p class="hugin">1,725</p> </td>
    <td class="hugin">
        <p class="hugin">100%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Cost of sales</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">851</p> </td>
    <td class="hugin">
        <p class="hugin">44.6%</p> </td>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">867</p> </td>
    <td class="hugin">
        <p class="hugin">50.2%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Gross profit</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">1,058</p> </td>
    <td class="hugin">
        <p class="hugin">55.4%</p> </td>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">858</p> </td>
    <td class="hugin">
        <p class="hugin">49.8%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">R&amp;D expenses</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">154</p> </td>
    <td class="hugin">
        <p class="hugin">8.1%</p> </td>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">154</p> </td>
    <td class="hugin">
        <p class="hugin">8.9%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">S&amp;M expenses</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">273</p> </td>
    <td class="hugin">
        <p class="hugin">14.3%</p> </td>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">261</p> </td>
    <td class="hugin">
        <p class="hugin">15.1%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">G&amp;A expenses</p> </td>
    <td style="vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">96</p> </td>
    <td class="hugin">
        <p class="hugin">5.0%</p> </td>
    <td class="hugin">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td class="hugin">
        <p class="hugin">93</p> </td>
    <td class="hugin">
        <p class="hugin">5.4%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other</p> </td>
    <td style="border-bottom: solid black 1pt ; vertical-align: bottom ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="border-bottom: solid black 1pt ; ">
        <p class="hugin">3</p> </td>
    <td style="border-bottom: solid black 1pt ; ">
        <p class="hugin">&#167;</p> </td>
    <td style="border-bottom: solid black 1pt ; ">
        <p class="hugin" style="margin: 0in; font-size:11pt; font-family:&quot;Calibri&quot;; margin-top:0in; margin-right:0in; margin-bottom:0in; margin-left:0in;">&#160;</p>
        </td>
    <td style="border-bottom: solid black 1pt ; ">
        <p class="hugin">1</p> </td>
    <td style="border-bottom: solid black 1pt ; ">
        <p class="hugin">&#167;</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Segment profit*</p> </td>
    <td style="border-bottom: double black 3pt ; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-bottom: double black 3pt ; ">
        <p class="hugin">532</p> </td>
    <td style="border-bottom: double black 3pt ; ">
        <p class="hugin">27.9%</p> </td>
    <td style="border-bottom: double black 3pt ; ">
        <p class="hugin">$</p> </td>
    <td style="border-bottom: double black 3pt ; ">
        <p class="hugin">350</p> </td>
    <td style="border-bottom: double black 3pt ; ">
        <p class="hugin">20.3%</p> </td></tr>
  <tr>
    <td colspan="7" style="vertical-align: bottom ; ">
        <p class="hugin">* Segment profit does not include amortization and certain other items.<br >&#167; Represents an amount less than 0.5%.</p>
        </td></tr>
  </table>

<p>&#160;<br ></p>

<p><strong>Revenues</strong> from our United States segment in the first quarter of 2025 were $1,910 million, an increase of $184 million,
or 11%, compared to the first quarter of 2024. This increase was mainly due to higher revenues from our innovative products, mainly AUSTEDO
and UZEDY, as well as higher revenues from generic products.</p>

<p><strong><em>Revenues by Major Products and Activities</em></strong></p>

<p>The following table presents revenues for our United States segment by major products and activities for the three months ended March
31, 2025 and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>Three months ended</strong><br ><strong>March 31,</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: top ; ">
        <p class="hugin"><strong>Percentage</strong><br ><strong>Change</strong>&#160;</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025-2024</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions)</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="max-width:47%; width:47%; min-width:47%;;vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Generic products (including biosimilars)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">849</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">808</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">5%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">AJOVY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">53</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">45</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">18%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">AUSTEDO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">396</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">282</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">40%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">BENDEKA and TREANDA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">36</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">46</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(20%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">COPAXONE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">54</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">30</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">79%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">UZEDY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">39</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">15</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">156%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Anda&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">373</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">381</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(2%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">109</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">117</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(7%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">1,910</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">1,725</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">11%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td></tr>
  </table>

<p><strong>Generic products</strong> (including biosimilars) revenues in our United States segment in the first quarter of 2025 were $849
million, an increase of 5% compared to the first quarter of 2024. This increase was mainly driven by higher revenues from lenalidomide
capsules (the generic version of Revlimid<sup>&#174;</sup>) and the launch of SIMLANDI (adalimumab-ryvk) injection (the biosimilar to
Humira<sup>&#174;</sup>).</p>

<p>Among the most significant generic products we sold in the United States in the first quarter of 2025 were lenalidomide capsules (the
generic version of Revlimid<sup>&#174;</sup>), Truxima<sup>&#174;</sup> (the biosimilar to Rituxan<sup>&#174;</sup>) and epinephrine injectable
solution (the generic equivalent of EpiPen<sup>&#174;</sup> and EpiPen Jr<sup>&#174;</sup>). In the first quarter of 2025, our total prescriptions
were approximately 273 million (based on trailing twelve months), representing 7.1% of total U.S. generic prescriptions, compared to approximately
314 million (based on trailing twelve months), representing 8.2% of total U.S. generic prescriptions in the first quarter of 2024, all
according to IQVIA data.</p>

<p>On February 21, 2025, Teva launched SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara<sup>&#174;</sup>,
for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients six years
and older. On May 5, 2025, Teva and Alvotech announced that the FDA has approved SELARSDI (ustekinumab-aekn) injection as interchangeable
with the reference biologic Stelara<sup>&#174; </sup>(ustekinumab) in all presentations matching the reference product, effective as of
April 30, 2025.</p>

<p><strong>AJOVY </strong>revenues in our United States segment in the first quarter of 2025 were $53 million, an increase of 18% compared
to the first quarter of 2024, mainly due to growth in volume. In the first quarter of 2025, AJOVY&#8217;s exit market share in the United
States in terms of total number of prescriptions was 30.2% compared to 27.4% in the first quarter of 2024.</p>

<p><strong>AUSTEDO</strong> revenues in our United States segment in the first quarter of 2025 increased by 40%, to $396 million, compared
to $282 million in the first quarter of 2024. This increase was mainly due to growth in volume, including the approval of AUSTEDO XR one
pill, once-daily treatment in May 2024.</p>

<p><strong>AUSTEDO XR</strong> (deutetrabenazine) extended-release tablets was approved by the FDA on February 17, 2023 in three doses
of 6, 12 and 24 mg, and became commercially available in the U.S. in May 2023. The FDA approved AUSTEDO XR as a one pill, once-daily treatment
option in doses of 30, 36, 42, and 48 mg in May 2024 and in 18 mg in July 2024. AUSTEDO XR is a once-daily formulation indicated in adults
for tardive dyskinesia and chorea associated with Huntington&#8217;s disease, which is additional to the currently marketed twice-daily
AUSTEDO. AUSTEDO XR is protected by 11 Orange Book patents expiring between 2031 and 2041.</p>

<p>On January 17, 2025, the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) released a list of prescription medicines selected
for price-setting discussions, which included AUSTEDO and AUSTEDO XR. The price-setting process has commenced, and the revised prices
set by the government, which will apply to eligible Medicare patients, are expected to become effective on January 1, 2027. As the price-setting
process is still in its early stages, the extent to which prices for AUSTEDO and AUSTEDO XR will change as a result of such discussions
remains uncertain.</p>

<p><strong>UZEDY </strong>(risperidone) extended-release injectable suspension revenues in our United States segment in the first quarter
of 2025 were $39 million, an increase of 156% compared to the first quarter of 2024, mainly due to growth in volume. UZEDY (risperidone)
extended-release injectable suspension was approved by the FDA on April 28, 2023 for the treatment of schizophrenia in adults, and was
launched in the U.S. in May 2023. UZEDY is a subcutaneous, long-acting formulation of risperidone that controls the steady release of
risperidone. UZEDY is protected by four Orange Book patents expiring between 2027 and 2040. UZEDY is protected by regulatory exclusivity
until April 28, 2026. We are moving forward with plans to launch UZEDY in other countries around the world. UZEDY faces competition from
multiple other products.</p>

<p><strong>BENDEKA</strong> and <strong>TREANDA</strong> combined revenues in our United States segment in the first quarter of 2025 were
$36 million, a decrease of 20% compared to the first quarter of 2024, mainly due to competition from alternative therapies, as well as
the entry of generic bendamustine products into the market. The orphan drug exclusivity that had attached to bendamustine products expired
in December 2022.</p>

<p><strong>COPAXONE</strong> revenues in our United States segment in the first quarter of 2025 were $54 million, an increase of 79% compared
to the first quarter of 2024, mainly due to reduction in sales allowance, partially offset by market share erosion and competition.</p>

<p><strong>Anda</strong> revenues from third-party products in our United States segment in the first quarter of 2025 were $373 million,
a decrease of 2%, compared to $381 million in the first quarter of 2024. This decrease was mainly due to lower volumes. Anda, our distribution
business in the United States, distributes generic and innovative medicines and OTC pharmaceutical products from Teva and various third-party
manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals and physician offices in the United States. Anda is
able to compete in the distribution market by maintaining a broad portfolio of products, competitive pricing and delivery throughout the
United States.</p>

<p><strong><em>United States Gross Profit</em></strong></p>

<p><strong>Gross profit </strong><strong>from</strong> our United States segment in the first quarter of 2025 was $1,058 million, an increase
of 23%, compared to $858 million in the first quarter of 2024.</p>

<p><strong>Gross profit margin</strong> for our United States segment in the first quarter of 2025 increased to 55.4%, compared to 49.8%
in the first quarter of 2024. This increase was mainly due to a favorable mix of products primarily driven by higher revenues from AUSTEDO.</p>

<p><strong><em>United States Profit </em></strong></p>

<p>Profit from our United States segment consists of revenues less cost of sales, R&amp;D expenses, S&amp;M expenses, G&amp;A expenses
and other expenses (income) related to this segment. Segment profit does not include amortization and certain other items. <strong>Profit</strong>
from our United States segment in the first quarter of 2025 was $532 million, an increase of 52% compared to $350 million in the first
quarter of 2024. This increase was mainly due to higher gross profit, as discussed above.</p>

<p><strong>Europe Segment</strong></p>

<p>Our Europe segment includes the European Union, the United Kingdom and certain other European countries.</p>

<p>The following table presents revenues, expenses and profit for our Europe segment for the three months ended March 31, 2025 and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="vertical-align: middle ; ">&#160;</td>
    <td colspan="6" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin"><strong>Three months ended March 31,</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="3" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="6" style="text-align: right ; vertical-align: middle; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions / % of Segment Revenues)</strong></p> </td></tr>
  <tr>
    <td style="max-width:34%; width:34%; min-width:34%;;vertical-align: bottom ; ">
        <p class="hugin">Revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">1,194</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">100%</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">1,272</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">100%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Cost of sales&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">536</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">44.9%</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">534</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">42.0%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Gross profit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">658</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">55.1%</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">738</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">58.0%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">R&amp;D expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">60</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">5.1%</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">56</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">4.4%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">S&amp;M expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">199</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">16.7%</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">194</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">15.2%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">G&amp;A expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">69</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">5.8%</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">65</p> </td>
    <td style="text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">5.1%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="border-bottom: solid black 1pt ; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">1</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Segment profit*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">329</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">27.6%</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">423</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">33.2%</p> </td></tr>
  <tr>
    <td colspan="7" style="vertical-align: top ; ">
        <p class="hugin">* Segment profit does not include amortization and certain other items.<br >&#167; Represents an amount less than $0.5
        million or 0.5%, as applicable.</p> </td></tr>
  <tr>
    <td colspan="7" style="vertical-align: top ; ">&#160;</td></tr>
  </table>

<p><strong>Revenues</strong> from our Europe segment in the first quarter of 2025 were $1,194 million, a decrease of 6%, or $78 million,
compared to the first quarter of 2024. In local currency terms, revenues decreased by 2% compared to the first quarter of 2024, mainly
due to lower revenues from COPAXONE and from the sale of mature innovative product rights in 2024, partially offset by higher revenues
from AJOVY.</p>

<p>In the first quarter of 2025, revenues were negatively impacted by exchange rate fluctuations of $55 million, including hedging effects,
compared to the first quarter of 2024. Revenues in the first quarter of 2025, included $12 million from a negative hedging impact, which
is included in &#8220;Other&#8221; in the table below. Revenues in the first quarter of 2024 included $8 million from a positive hedging
impact, which is included in &#8220;Other&#8221; in the table below.</p>

<p><strong><em>Revenues by Major Products and Activities</em></strong></p>

<p>The following table presents revenues for our Europe segment by major products and activities for the three months ended March 31,
2025 and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="7" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>Three months ended</strong><br ><strong>March 31,</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>Percentage</strong><br ><strong>Change</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td colspan="2" style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="3" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025-2024</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="7" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions)</strong></p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="max-width:47%; width:47%; min-width:47%;;vertical-align: bottom ; ">
        <p class="hugin">Generic products (including OTC and biosimilars)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td colspan="2" style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">989</p> </td>
    <td colspan="2" style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">1,004</p> </td>
    <td colspan="2" style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(1%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">AJOVY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">58</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">51</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">14%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">COPAXONE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">42</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">57</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(27%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Respiratory products&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">55</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">66</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(18%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">50</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">94</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(46%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">1,194</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">1,272</p> </td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(6%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td></tr>
  </table>

<p><strong>Generic products </strong>revenues (including OTC and biosimilar products) in our Europe segment in the first quarter of 2025,
were $989 million, a decrease of 1% compared to the first quarter of 2024. In local currency terms, revenues increased by 1%, mainly due
to higher volumes and price increases as a result of market conditions such as inflationary pressures in certain markets, as well as revenues
from recently launched products.</p>

<p><strong>AJOVY </strong>revenues in our Europe segment in the first quarter of 2025 increased by 14% to $58 million, compared to $51
million in the first quarter of 2024. In local currency terms revenues increased by 18% due to growth in volume.</p>

<p><strong>COPAXONE</strong> revenues in our Europe segment in the first quarter of 2025 were $42 million, a decrease of 27% compared
to the first quarter of 2024. In local currency terms revenues decreased by 24%, due to price reductions and a decline in volume resulting
from the availability of alternative therapies and competing glatiramer acetate products.</p>

<p>In certain countries, Teva remains in litigation against generic companies regarding COPAXONE.</p>

<p><strong>Respiratory products</strong> revenues in our Europe segment in the first quarter of 2025 were $55 million, a decrease of 18%
compared to the first quarter of 2024. In local currency terms, revenues decreased by 16%, mainly due to net price reductions and lower
volumes.</p>

<p><strong><em>Europe Gross Profit </em></strong></p>

<p><strong>Gross profit</strong> from our Europe segment in the first quarter of 2025 was $658 million, a decrease of 11% compared to
$738 million in the first quarter of 2024.</p>

<p><strong>Gross profit margin</strong> for our Europe segment in the first quarter of 2025 decreased to 55.1%, compared to 58.0% in the
first quarter of 2024. This decrease was mainly due to a negative impact from hedging activities and unfavorable mix of products.</p>

<p><strong><em>Europe Profit </em></strong></p>

<p>Profit of our Europe segment consists of revenues less cost of sales, R&amp;D expenses, S&amp;M expenses, G&amp;A expenses and other
expenses (income) related to this segment. Segment profit does not include amortization and certain other items.</p>

<p><strong>Profit</strong> from our Europe segment in the first quarter of 2025 was $329 million, a decrease of 22%, compared to $423
million in the first quarter of 2024. This decrease was mainly due to lower gross profit, as discussed above.</p>

<p><strong>International Markets Segment</strong></p>

<p>Our International Markets segment includes all countries in which we operate other than the United States and the countries included
in our Europe segment. The International Markets segment covers a substantial portion of the global pharmaceutical industry, including
more than 35 countries.</p>

<p>The countries in our International Markets segment include highly regulated, mainly generic markets, such as Canada and Israel, branded
generics-oriented markets, such as Russia and certain Latin America markets and hybrid markets, such as Japan.</p>

<p>On March 31, 2025, we closed the sale of our Teva-Takeda business venture in Japan. The business venture included generic products
and legacy products.</p>

<p>The following table presents revenues, expenses and profit for our International Markets segment for the three months ended March 31,
2025 and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="vertical-align: middle ; ">&#160;</td>
    <td colspan="6" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin"><strong>Three months ended March 31,</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="3" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="6" style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions / % of Segment Revenues)</strong></p> </td></tr>
  <tr>
    <td style="max-width:34%; width:34%; min-width:34%;;vertical-align: bottom ; ">
        <p class="hugin">Revenues&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">582</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">100%</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">597</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">100%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Cost of sales&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">304</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">52.3%</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">300</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">50.3%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Gross profit&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">278</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">47.7%</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">297</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">49.7%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">R&amp;D expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">25</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">4.3%</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">28</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">4.6%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">S&amp;M expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">118</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">20.2%</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">118</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">19.8%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">G&amp;A expenses&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">39</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">6.7%</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">35</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">5.8%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">(1)</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">&#167;</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Segment profit*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">97</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">16.7%</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">117</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">19.6%</p> </td></tr>
  <tr>
    <td colspan="6" style="vertical-align: top ; ">
        <p class="hugin">* Segment profit does not include amortization and certain other items.<br >&#167; Represents an amount less than $0.5
        million or 0.5%, as applicable.</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td colspan="6" style="vertical-align: top ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td></tr>
  </table>

<p><strong>Revenues</strong> from our International Markets segment in the first quarter of 2025 were $582 million, a decrease of 2% compared
to the first quarter of 2024. In local currency terms, revenues increased by 5% compared to the first quarter of 2024. This decrease was
mainly due to higher revenues from AJOVY as well as generic products in most markets, partially offset by regulatory price reductions
and generic competition to off-patented products in Japan.</p>

<p>In the first quarter of 2025, revenues were negatively impacted by exchange rate fluctuations of $44 million, including hedging effects,
compared to the first quarter of 2024. Revenues in the first quarter of 2025 included $15 million from a negative hedging impact, compared
to a positive hedging impact of $4 million in the first quarter of 2024, which are included in &#8220;Other&#8221; in the table below.</p>

<p><strong><em>Revenues by Major Products and Activities</em></strong></p>

<p>The following table presents revenues for our International Markets segment by major products and activities for the three months ended
March 31, 2025 and 2024:</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>Three months ended</strong><br ><strong>March 31,</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>Percentage</strong><br ><strong>Change</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025</strong></p> </td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2024</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>2025-2024</strong></p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin"><strong>(U.S. $ in millions)</strong></p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td></tr>
  <tr>
    <td style="max-width:47%; width:47%; min-width:47%;;vertical-align: bottom ; ">
        <p class="hugin">Generic products (including OTC and biosimilars)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">468</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">477</p> </td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(2%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">AJOVY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">28</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">17</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">65%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">AUSTEDO &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">15</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">14</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">4%</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">COPAXONE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">10</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">12</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(11%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Other*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">61</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">77</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(21%)</p> </td></tr>
  <tr>
    <td style="vertical-align: bottom ; ">
        <p class="hugin">Total&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p> </td>
    <td style="vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">582</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">$</p> </td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">597</p> </td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; vertical-align: bottom ; ">
        <p class="hugin">(2%)</p> </td></tr>
  <tr>
    <td colspan="9" style="vertical-align: middle ; ">
        <p class="hugin">* Other revenues in the first quarter of 2025 include the sale of certain product rights.</p> </td></tr>
  <tr>
    <td colspan="9" style="vertical-align: middle ; ">&#160;</td></tr>
  </table>

<p><strong>Generic products</strong> revenues (including OTC and biosimilar products) in our International Markets segment were $468 million
in the first quarter of 2025, a decrease of 2% compared to the first quarter of 2024. In local currency terms, revenues increased by 2%
compared to the first quarter of 2024, mainly due to higher revenues in most markets, largely driven by price increases as a result of
higher costs due to inflationary pressure in certain markets and higher volumes, partially offset by regulatory price reductions and generic
competition to off-patented products in Japan.</p>

<p><strong>AJOVY </strong>was launched in certain markets in our International Markets segment, including in Canada, Japan, Australia,
Israel, South Korea, Brazil and others. AJOVY revenues in our International Markets segment in the first quarter of 2025 were $28 million,
compared to $17 million in the first quarter of 2024, due to growth in existing markets in which AJOVY was launched.</p>

<p><strong>AUSTEDO </strong>was launched in China and Israel in 2021 and in Brazil in 2022, for the treatment of chorea associated with
Huntington&#8217;s disease and for the treatment of tardive dyskinesia. In February 2024, we announced a strategic partnership for the
marketing and distribution of AUSTEDO in China. We continue to pursue additional submissions in various other markets.</p>

<p>AUSTEDO revenues in our International Markets segment in the first quarter of 2025 were $15 million compared to $14 million in the
first quarter of 2024. In local currency terms, revenues increased by 6%, substantially due to the launch of a strategic partnership in
China.</p>

<p><strong>COPAXONE</strong> revenues in our International Markets segment in the first quarter of 2025 were $10 million compared to $12
million in the first quarter of 2024.</p>

<p><strong><em>International Markets Gross Profit </em></strong></p>

<p><strong>Gross profit</strong> from our International Markets segment in the first quarter of 2025 was $278 million, a decrease of 6%
compared to $297 million in the first quarter of 2024.</p>

<p><strong>Gross profit margin</strong> for our International Markets segment in the first quarter of 2025 decreased to 47.7%, compared
to 49.7% in the first quarter of 2024. This decrease was mainly due to a negative hedging impact, as well as regulatory price reductions
and generic competition to off-patented products in Japan.</p>

<p><strong><em>International Markets Profit </em></strong></p>

<p>Profit of our International Markets segment consists of revenues less cost of sales, R&amp;D expenses, S&amp;M expenses, G&amp;A expenses
and other expenses (income) related to this segment. Segment profit does not include amortization and certain other items. Profit from
our International Markets segment in the first quarter of 2025 was $97 million, a decrease of 17%, compared to $117 million in the first
quarter of 2024. This decrease was mainly due to lower gross profit, as discussed above.</p>

<p><strong>Other Activities </strong></p>

<p>We have other sources of revenues, primarily the sale of APIs to third parties, certain contract manufacturing services and an out-licensing
platform offering a portfolio of products to other pharmaceutical companies through our affiliate Medis. Our other activities are not
included in our United States, Europe or International Markets segments described above.</p>

<p>On January 31, 2024, we announced that we intend to divest our API business (including its R&amp;D, manufacturing and commercial activities)
through a sale. The intention to divest is in alignment with our Pivot to Growth strategy. However, there can be no assurance regarding
the ultimate timing or structure of a potential divestiture or that a divestiture will be agreed or completed at all.</p>

<p>Revenues from <strong>other activities</strong> in the first quarter of 2025 were $206 million, a decrease of 9% in U.S. dollars or
8% in local currency terms, compared to the first quarter of 2024, mainly due to a decrease in revenues from contract manufacturing services
in the first quarter of 2025.</p>

<p>API sales to third parties in the first quarter of 2025 were $130 million, reflecting an increase of 2% in both U.S. dollars and local
currency terms, compared to the first quarter of 2024.</p>

<p><strong>Outlook for 202</strong><strong>5</strong><strong> Non-GAAP Results</strong></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="2" style="max-width:66%; width:66%; min-width:66%;;vertical-align: middle; text-align: left; padding-left: 15.0px; border-bottom: solid black 1pt ; vertical-align: middle ; ">
        <p class="hugin">$ billions, except EPS or as noted</p> </td>
    <td colspan="2" style="max-width:1%; width:1%; min-width:1%;;vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="max-width:16%; width:16%; min-width:16%;;border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">January 2025 Outlook</p> </td>
    <td colspan="2" style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; vertical-align: top ; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; vertical-align: middle ; ">
        <p class="hugin">May 2025 Outlook</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; border-top: solid black 1pt ; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Revenues*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; border-top: solid black 1pt ; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">$16.8 - $17.4</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; border-top: solid black 1pt ; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">$16.8 - $17.2</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">AUSTEDO ($m)*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">1,900-2,050</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">1,950-2,050</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">AJOVY ($m)*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~600</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~600</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">UZEDY ($m)*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~160</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~160</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">COPAXONE ($m)*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~370</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~370</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Operating Income</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">4.1 - 4.6</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">4.3 - 4.6</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Adjusted EBITDA</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">4.5 - 5.0</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">4.7 - 5.0</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">Tax Rate</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">15%-18%</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">15%-18%</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Finance Expenses</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~0.9</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~0.9</p></td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Diluted EPS ($)</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">2.35 - 2.65</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">2.45 - 2.65</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">Free Cash Flow**</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">1.6 &#8211; 1.9</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">1.6 &#8211; 1.9</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">CAPEX*</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin" dir="RTL">~0.5</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="2" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">~0.5</p> </td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">Foreign Exchange</p> </td>
    <td colspan="2" style="vertical-align: top ; ">&#160;</td>
    <td colspan="6" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">Volatile swings in FX can negatively impact revenue and income</p> </td></tr>
  <tr>
    <td colspan="9" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">
        <p class="hugin">* Revenues and CAPEX presented on a GAAP basis. <br >** Free Cash Flow includes cash flow generated from operating activities
        net of capital expenditures and deferred purchase price cash component collected for securitized trade receivables.</p> </td></tr>
  <tr>
    <td colspan="9" style="vertical-align: middle; text-align: left; padding-left: 15.0px; vertical-align: middle ; ">&#160;</td></tr>
  </table>

<p><strong>Conference Call</strong></p>

<p>Teva will host a conference call and live webcast along with a slide presentation on Wednesday, May 7, 2025 at 8:00 a.m. ET to discuss
its first quarter 2025 financial results and overall business environment.</p>

<p>A question &amp; answer session will follow.</p>

<p align="left">In&#160;order&#160;to&#160;participate,&#160;please&#160;register&#160;in&#160;advance&#160;here&#160;to&#160;obtain&#160;a&#160;local&#160;or&#160;toll&#8208;free&#160;phone&#160;number&#160;and&#160;your
personal&#160;pin.</p>

<p align="left">A live webcast of the call will be available on Teva's website at: <u>www.tevapharm.com</u></p>

<p>Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva's website.</p>

<p><strong>About Teva</strong></p>

<p>Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates
across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva&#8217;s commitment
to bettering health has never wavered. Today, the company&#8217;s global network of capabilities enables its 37,000 employees across 57
markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated
to addressing patients&#8217; needs, now and in the future. Moving forward together with science that treats, inspired by the people we
serve. To learn more about how Teva is all in for better health, visit <u>www.tevapharm.com</u>.</p>

<p>Some amounts in this press release may not add up due to rounding. All percentages have been calculated using unrounded amounts.</p>

<p><strong>Non-GAAP Financial Measures</strong></p>

<p>This press release contains certain financial information that differs from what is reported under accounting principles generally
accepted in the United States ("GAAP"). These non-GAAP financial measures, including, but not limited to, non-GAAP operating income, non-GAAP
operating margin, non-GAAP gross profit, non-GAAP gross profit margin, Adjusted EBITDA, free cash flow, non-GAAP tax rate, non-GAAP net
income (loss) attributable to Teva and non-GAAP diluted EPS, are presented in order to facilitate investors' understanding of our business.
We utilize certain non-GAAP financial measures to evaluate performance, in conjunction with other performance metrics. The following are
examples of how we utilize the non-GAAP measures: our management and board of directors use the non-GAAP measures to evaluate our operational
performance, to compare against work plans and budgets, and ultimately to evaluate the performance of management; our annual budgets are
prepared on a non-GAAP basis; and senior management&#8217;s annual compensation is derived, in part, using these non-GAAP measures. See
the attached tables for a reconciliation of the GAAP results to the adjusted non-GAAP measures. Investors should consider non-GAAP financial
measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP.
We are not providing forward looking guidance for GAAP reported financial measures or a quantitative reconciliation of forward-looking
non-GAAP financial measures to the most directly comparable GAAP measure because we are unable to predict with reasonable certainty the
ultimate outcome of certain significant items including, but not limited to, the amortization of purchased intangible assets, legal settlements
and loss contingencies, impairment of long-lived assets and goodwill impairment, without unreasonable effort. These items are uncertain,
depend on various factors, and could be material to our results computed in accordance with GAAP.</p>

<p align="justify"><strong>Cautionary Note Regarding Forward-Looking Statements</strong></p>

<p align="left">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform
Act of 1995, which are based on management&#8217;s current beliefs and expectations and are subject to substantial risks and uncertainties,
both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or
implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as &#8220;should,&#8221;
&#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;project,&#8221;
&#8220;guidance,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe&#8221; and other words and terms of similar meaning and
expression in connection with any discussion of future operating or financial performance. These forward-looking statements include statements
concerning our plans, strategies, objectives, future performance and financial and operating targets, and any other information that is
not historical information. Important factors that could cause or contribute to such differences include risks relating to:</p>

<ul type="disc">

<li style="margin-bottom:6pt;">our ability to successfully compete in the marketplace, including: that we are substantially dependent
on our generic products; concentration of our customer base and commercial alliances among our customers; competition faced by our generic
medicines from other pharmaceutical companies and changes in regulatory policy that may result in additional costs and delays; delays
in launches of new generic products; our ability to develop and commercialize additional pharmaceutical products; competition for our
innovative medicines; our ability to achieve expected results from investments in our product pipeline; our ability to successfully execute
our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative
medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic
medicines, and to execute on our organizational transformation and to achieve expected cost savings; and the effectiveness of our patents
and other measures to protect our intellectual property rights, including any potential challenges to our Orange Book patent listings
in the U.S.;</li>

<li style="margin-bottom:6pt;">our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional
transactions or make new investments; and our potential need to raise additional funds in the future, which may not be available on acceptable
terms or at all;</li>

<li style="margin-bottom:6pt;">our business and operations in general, including: the impact of global economic conditions and other macroeconomic
developments and the governmental and societal responses thereto; the widespread outbreak of an illness or any other communicable disease,
or any other public health crisis; effectiveness of our optimization efforts; significant disruptions of information technology systems,
including cybersecurity attacks and breaches of our data security; interruptions in our supply chain or problems with internal or third
party manufacturing; challenges associated with conducting business globally, including political or economic instability, major hostilities
or terrorism, such as the ongoing conflict between Russia and Ukraine and the state of war declared in Israel; our ability to attract,
hire, integrate and retain highly skilled personnel; our ability to successfully bid for suitable acquisition targets or licensing opportunities,
or to consummate and integrate acquisitions; and our prospects and opportunities for growth if we sell assets or business units and close
or divest plants and facilities, as well as our ability to successfully and cost-effectively consummate such sales and divestitures, including
our planned divestiture of our API business;</li>

<li style="margin-bottom:6pt;">compliance, regulatory and litigation matters, including: failure to comply with complex legal and regulatory
environments; the effects of governmental and civil proceedings and litigation which we are, or in the future become, party to; the effects
of reforms in healthcare regulation and reductions in pharmaceutical pricing, reimbursement and coverage; increased legal and regulatory
action in connection with public concern over the abuse of opioid medications; our ability to timely make payments required under our
nationwide opioids settlement agreement and provide our generic version of Narcan<sup>&#174;</sup> (naloxone hydrochloride nasal spray)
in the amounts and at the times required under the terms of such agreement; scrutiny from competition and pricing authorities around the
world, including our ability to comply with and operate under our deferred prosecution agreement (&#8220;DPA&#8221;) with the U.S. Department
of Justice (&#8220;DOJ&#8221;); potential liability for intellectual property right infringement; product liability claims; failure to
comply with complex Medicare, Medicaid and other governmental programs reporting and payment obligations; compliance with sanctions and
trade control laws; environmental risks; and the impact of ESG issues;</li>

<li style="margin-bottom:6pt;">the impact of the state of war declared in Israel and the military activity in the region, including the
risk of disruptions to our operations and facilities, such as our manufacturing and R&amp;D facilities, located in Israel, the impact
of our employees who are military reservists being called to active military duty, and the impact of the war on the economic, social and
political stability of Israel;</li>

<li style="margin-bottom:6pt;">other financial and economic risks, including: our exposure to currency fluctuations and restrictions as
well as credit risks; potential impairments of our long-lived assets; the impact of geopolitical conflicts including the state of war
declared in Israel and the conflict between Russia and Ukraine; potential significant increases in tax liabilities; the effect on our
overall effective tax rate of the termination or expiration of governmental programs or tax benefits, or of a change in our business;
our exposure to changes in international trade policies, including the imposition of tariffs in the jurisdictions in which we operate,
and the effects of such developments on sales of our products and the pricing and availability of our raw materials; and the impact of
any future failure to establish and maintain effective internal control over our financial reporting;</li></ul>

<p>and other factors discussed in this press release, in our Quarterly Report on Form 10-Q for the first quarter of 2025 and in our Annual
Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Risk Factors&#8221; and &#8220;Forward
Looking Statements.&#8221; Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to
update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future
events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.</p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="max-width:48%; width:48%; min-width:48%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="8" style="text-align: center ; vertical-align: middle; "><strong>Consolidated Statements of Income </strong></td></tr>
  <tr>
    <td colspan="8" style="text-align: center ; vertical-align: middle; ">(U.S. dollars in millions, except share and per share data)</td></tr>
  <tr>
    <td colspan="8" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="4" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="4" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net revenues</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">3,891</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">3,819</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Cost of sales</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">2,014</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">2,048</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Gross profit</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,877</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,771</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Research and development expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">247</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">242</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Selling and marketing expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">622</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">608</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">General and administrative expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">297</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">278</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Intangible assets impairments</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">121</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">80</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other asset impairments, restructuring and other items</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(22)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">673</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Legal settlements and loss contingencies</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">86</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">106</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other loss (income)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">5</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Operating income (loss)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">519</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(218)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Financial expenses, net</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">225</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">250</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Income (loss) before income taxes</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">294</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(467)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Income taxes (benefit)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">74</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(52)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Share in (profits) losses of associated companies, net</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">*</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">4</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net income (loss)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">220</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(419)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net income (loss) attributable to redeemable and non-redeemable non-controlling interests</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">6</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(280)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net income (loss) attributable to Teva</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">214</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">(139)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-top: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">Earnings (loss) per share
        attributable to Teva:</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">Basic ($)</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">0.19</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(0.12)</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Diluted ($)</td>
    <td style="text-align: right ; vertical-align: middle; ">0.18</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(0.12)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">Weighted average number of shares (in millions):</td>
    <td style="text-align: left ; vertical-align: middle; ">Basic</td>
    <td style="text-align: right ; vertical-align: middle; ">1,138</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,123</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;&#160;&#160;&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">Diluted</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,159</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,123</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-top: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">Non-GAAP net income attributable
        to Teva for diluted earnings per share:*</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">602</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">548</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">Non-GAAP earnings per share attributable to Teva:*</td>
    <td style="text-align: left ; vertical-align: middle; ">Diluted ($)</td>
    <td style="text-align: right ; vertical-align: middle; ">0.52</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">0.48</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">Non-GAAP average number of shares (in millions):</td>
    <td style="text-align: left ; vertical-align: middle; ">Diluted</td>
    <td style="text-align: right ; vertical-align: middle; ">1,159</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,143</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-bottom: solid black 1pt ; border-left: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;&#160;&#160;&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-right: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>Amounts may not add up due to rounding</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">* Represents an amount less than $0.5 million.</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">** See reconciliation attached.</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="10" style="text-align: center ; vertical-align: middle; "><strong>CONSOLIDATED BALANCE SHEETS </strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="10" style="text-align: center ; vertical-align: middle; "><strong>(U.S. dollars in millions, except for share data) </strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="10" style="text-align: center ; vertical-align: middle; "><strong>(Unaudited)</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="max-width:60%; width:60%; min-width:60%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>December 31,</strong></td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>ASSETS</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Current assets:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Cash and cash equivalents</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,697</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">3,300</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Accounts receivables, net of allowance for credit losses of $80 million
        and $78 million as of March 31, 2025 and December 31, 2024, respectively</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,384</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,059</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Inventories</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,247</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,007</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Prepaid expenses</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,018</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,006</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Other current assets</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">368</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">409</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Assets held for sale</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,814</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,771</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total current assets</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">11,528</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">12,552</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Deferred income taxes</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,762</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,799</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Other non-current assets</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">464</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">462</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Property, plant and equipment, net</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,631</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,581</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Operating lease right-of-use assets, net</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">363</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">367</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Identifiable intangible assets, net</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,189</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,418</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Goodwill</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">15,477</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">15,147</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total assets</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">38,415</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">39,326</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>LIABILITIES AND EQUITY</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Current liabilities:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Short-term debt</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">421</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,781</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Sales reserves and allowances</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,696</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">3,678</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Accounts payables</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2,290</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2,203</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Employee-related obligations</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">474</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">624</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Accrued expenses</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2,952</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2,792</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Other current liabilities</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">964</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,020</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Liabilities held for sale</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">358</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">698</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total current liabilities</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">11,157</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">12,796</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Long-term liabilities:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Deferred income taxes</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">461</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">483</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Other taxes and long-term liabilities</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,011</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">4,028</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Senior notes and loans</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">16,230</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">16,002</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">Operating lease liabilities</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">288</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">296</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total long-term liabilities</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">20,990</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">20,809</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Redeemable non-controlling interests </strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">340</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Equity:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Teva shareholders&#8217; equity:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">6,262</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">5,373</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Non-controlling interests</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">7</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">7</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total equity</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">6,269</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">5,380</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="4" style="text-align: left ; vertical-align: middle; "><strong>Total liabilities and equity</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">38,415</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">39,326</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="10" style="text-align: center ; vertical-align: middle; "><strong>Amounts may not add up due to rounding</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="10" style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>TEVA PHARMACEUTICAL INDUSTRIES LIMITED</strong></td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS</strong></td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>(U.S. dollars in millions) </strong></td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>(Unaudited) </strong></td></tr>
  <tr>
    <td style="max-width:65%; width:65%; min-width:65%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin">&#160;</td>
    <td colspan="3" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="3" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Operating activities:</strong></td>
    <td style="border-top: solid black 1pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net income (loss)</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">220</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">(419)</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Adjustments to reconcile net income (loss) to net cash provided by operations:</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Depreciation and amortization</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">244</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">272</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Impairment of long-lived assets and assets held for sale</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">77</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">679</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net change in operating assets and liabilities</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(700)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(497)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Deferred income taxes &#8211; net and uncertain tax positions</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(189)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Stock-based compensation</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">34</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other items</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(8)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Net cash provided by (used in) operating activities</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(105)</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(124)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Investing activities:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Beneficial interest collected in exchange for securitized trade receivables</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">322</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">295</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Purchases of property, plant and equipment and intangible assets</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(127)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(124)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Proceeds from sale of business and long-lived assets, net</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">17</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Acquisition of businesses, net of cash acquired</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(15)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Purchases of investments and other assets .</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(11)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(12)</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Net cash provided by (used in) investing activities</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">201</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">144</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Financing activities:</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Repayment of senior notes and loans and other long-term liabilities</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(1,368)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Purchase of shares from redeemable and non-redeemable non-controlling interests</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(38)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(64)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Dividends paid to redeemable and non-redeemable non-controlling interests</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(340)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(78)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other financing activities</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">3</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(9)</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Net cash provided by (used in) financing activities</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(1,744)</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(151)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Translation adjustment on cash and cash equivalents</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">45</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(104)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Net change in cash, cash equivalents and restricted cash</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(1,603)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(236)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Balance of cash, cash equivalents at beginning of period</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">3,300</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">3,227</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Balance of cash, cash equivalents at end of period</strong></td>
    <td style="border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">1,697</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">2,991</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Non-cash financing and investing activities:</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Beneficial interest obtained in exchange for securitized accounts receivables</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">311</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">312</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>Amounts may not add up due to rounding</strong></td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br > <br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="7" style="text-align: center ; vertical-align: middle; "><strong>Reconciliation of net income (loss) attributable to Teva </strong></td></tr>
  <tr>
    <td colspan="7" style="text-align: center ; vertical-align: middle; "><strong>to Non-GAAP net income (loss) attributable to Teva</strong></td></tr>
  <tr>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:64%; width:64%; min-width:64%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="3" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="3" style="text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><em>($ in millions except per share amounts)</em></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Net income (Loss) attributable to Teva</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">214</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(139)</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Increase (decrease) for excluded items:</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Amortization of purchased intangible assets</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">145</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">152</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Legal settlements and loss contingencies<sup>(1)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">83</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">106</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Impairment of long-lived assets<sup>(2)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">77</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">679</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Restructuring costs</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">14</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">13</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Equity compensation</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">34</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Contingent consideration<sup>(3)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">11</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">79</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Financial expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">14</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">12</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Redeemable and non-redeemable non-controlling interests<sup>(4)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">2</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(284)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Other non-GAAP items<sup>(5)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">63</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">53</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Corresponding tax effects and unusual tax items<sup>(6)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(55)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(150)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Non-GAAP net income attributable to Teva</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">602</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">548</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Non-GAAP tax rate<sup>(7)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">17.5%</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">15.0%</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">GAAP diluted earnings (loss) per share attributable to Teva</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">0.18</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">(0.12)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">EPS difference<sup>(8)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">0.33</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">0.60</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Non-GAAP diluted EPS attributable to Teva<sup>(8)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">0.52</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">0.48</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Non-GAAP average number of shares (in millions)<sup>(8)</sup></td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,159</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,143</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(1)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">For the three months ended March 31, 2025 and March 31, 2024, adjustments
        for legal settlements and loss contingencies primarily consisted of $50 million and $64 million, respectively, attributable to an update
        to the estimated settlement provision for the Company&#8217;s opioid litigation (mainly the effect of the passage of time on the net present
        value of the discounted payments).</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(2)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">For the three months ended March 31, 2025, adjustments for impairment
        of long-lived assets consist of (a) $121 million impairment of long-lived intangible assets mainly related to products in the U.S. and
        Europe, (b) a favorable adjustment of $46 million related to the classification of the API business (including its R&amp;D, manufacturing
        and commercial activities) as held for sale. For the three months ended March 31, 2024, adjustments for impairment of long-lived assets
        primarily consisted of $577 million related to the classification of our business venture in Japan as held for sale.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(3)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">For the three months ended March 31, 2024, adjustments for contingent
        consideration primarily related to a change in the estimated future royalty payments to Allergan in connection with lenalidomide capsules
        (generic version of Revlimid<sup>&#174;</sup>) of $64 million.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(4)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">For the three months ended March 31, 2024, related to non-controlling
        interests portion of long-lived assets impairment of $577 million related to the classification of our business venture in Japan as held
        for sale.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(5)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">Other non-GAAP items include other exceptional items that we believe are
        sufficiently large that their exclusion is important to facilitate an understanding of trends in our financial results, primarily related
        to the rationalization of our plants, accelerated depreciation, certain inventory write-offs, material litigation fees and other unusual
        events.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(6)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">For the three months ended March 31, 2025 and March 31, 2024, adjustments
        for corresponding tax effects and unusual tax items exclusively consisted of the tax impact directly attributable to the pre-tax items
        that are excluded from non-GAAP net income included in the other adjustments to this table.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(7)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">Non-GAAP tax rate is tax expenses (benefit) excluding the impact of non-GAAP
        tax adjustments presented above as a percentage of income (loss) before income taxes excluding the impact of non-GAAP adjustments presented
        above.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">(8)</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">EPS difference and diluted non-GAAP EPS are calculated by dividing our
        non-GAAP net income attributable to Teva by our non-GAAP diluted weighted average number of shares.</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; vertical-align: top ; ">&#160;</td>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="max-width:2%; width:2%; min-width:2%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:65%; width:65%; min-width:65%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>Reconciliation of gross profit to Non-GAAP gross profit</strong></td></tr>
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><em>($ in millions)</em></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Gross profit</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,877</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">1,771</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Gross profit margin</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">48.2%</td>
    <td style="text-align: right ; vertical-align: middle; ">46.4%</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Increase (decrease) for excluded items: <sup>(1)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Amortization of purchased intangible assets</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">135</td>
    <td style="text-align: right ; vertical-align: middle; ">137</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Equity compensation</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">6</td>
    <td style="text-align: right ; vertical-align: middle; ">5</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Other non-GAAP items</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">37</td>
    <td style="text-align: right ; vertical-align: middle; ">50</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Non-GAAP gross profit</strong></td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">2,054</td>
    <td style="text-align: right ; vertical-align: middle; ">1,963</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Non-GAAP gross profit margin </strong><sup><strong>(2)</strong></sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">52.8%</td>
    <td style="text-align: right ; vertical-align: middle; ">51.4%</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">(1) For further explanations, refer to the footnotes under the "Reconciliation
        of net income (loss) attributable to Teva to Non-GAAP net income (loss) attributable to Teva" table.</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">(2) Non-GAAP gross profit margin is non-GAAP gross profit as a percentage
        of revenue.</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>Reconciliation of operating income (loss) to Non-GAAP operating
        income (loss)</strong></td></tr>
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="max-width:2%; width:2%; min-width:2%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:65%; width:65%; min-width:65%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><em>($ in millions)</em></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Operating income (loss)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">519</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">(218)</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Operating margin</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">13.3%</td>
    <td style="text-align: right ; vertical-align: middle; ">(5.7%)</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Increase (decrease) for excluded items: <sup>(1)</sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Amortization of purchased intangible assets</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">145</td>
    <td style="text-align: right ; vertical-align: middle; ">152</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Legal settlements and loss contingencies</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">83</td>
    <td style="text-align: right ; vertical-align: middle; ">106</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Impairment of long-lived assets</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">77</td>
    <td style="text-align: right ; vertical-align: middle; ">679</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Restructuring costs</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">14</td>
    <td style="text-align: right ; vertical-align: middle; ">13</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Equity compensation</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">34</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Contingent consideration</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">11</td>
    <td style="text-align: right ; vertical-align: middle; ">79</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Other non-GAAP items</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">63</td>
    <td style="text-align: right ; vertical-align: middle; ">53</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Non-GAAP operating income (loss)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">946</td>
    <td style="text-align: right ; vertical-align: middle; ">892</td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Non-GAAP operating margin</strong><sup><strong>(2)</strong></sup></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;$</td>
    <td style="text-align: right ; vertical-align: middle; ">24.3%</td>
    <td style="text-align: right ; vertical-align: middle; ">23.4%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">(1) For further explanations, refer to the footnotes under the "Reconciliation
        of net income (loss) attributable to Teva to Non-GAAP net income (loss) attributable to Teva" table.</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">(2) Non-GAAP operating margin is Non-GAAP operating income as a percentage
        of revenues.</td></tr>
  <tr>
    <td colspan="5" style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td class="hugin" style="max-width:10%; width:10%; min-width:10%;">&#160;</td>
    <td class="hugin" style="max-width:57%; width:57%; min-width:57%;">&#160;</td>
    <td class="hugin" style="max-width:1%; width:1%; min-width:1%;">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin" style="max-width:16%; width:16%; min-width:16%;">&#160;</td></tr>
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>Reconciliation of net income (loss) to adjusted EBITDA</strong></td></tr>
  <tr>
    <td colspan="5" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td colspan="2" style="text-align: center ; vertical-align: middle; "><strong>December 31,</strong></td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">($ in millions)</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; "><strong>Net income (loss)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>220</strong></td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>(419)</strong></td></tr>
  <tr>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Increase (decrease) for excluded items:<sup>(1)</sup></td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Financial expenses</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">225</td>
    <td style="text-align: right ; vertical-align: middle; ">250</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Income taxes</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">74</td>
    <td style="text-align: right ; vertical-align: middle; ">(52)</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Share in profits (losses) of associated companies &#8211;net</td>
    <td style="text-align: right ; vertical-align: middle; ">&#167;</td>
    <td style="text-align: right ; vertical-align: middle; ">4</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Depreciation</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">99</td>
    <td style="text-align: right ; vertical-align: middle; ">119</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Amortization</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">145</td>
    <td style="text-align: right ; vertical-align: middle; ">152</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>EBITDA</strong></td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; "><strong>763</strong></td>
    <td style="text-align: right ; vertical-align: middle; "><strong>54</strong></td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td colspan="2" style="text-align: left ; vertical-align: middle; ">Legal settlements and loss contingencies</td>
    <td style="text-align: right ; vertical-align: middle; ">83</td>
    <td style="text-align: right ; vertical-align: middle; ">106</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Impairment of long lived assets</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">77</td>
    <td style="text-align: right ; vertical-align: middle; ">679</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Restructuring costs</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">14</td>
    <td style="text-align: right ; vertical-align: middle; ">13</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Equity compensation</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">34</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Contingent consideration</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">11</td>
    <td style="text-align: right ; vertical-align: middle; ">79</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">Other non-GAAP items</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">59</td>
    <td style="text-align: right ; vertical-align: middle; ">46</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Adjusted EBITDA</strong></td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; "><strong>1,041</strong></td>
    <td style="text-align: right ; vertical-align: middle; "><strong>1,005</strong></td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">(1) For further explanations, refer to the footnotes under the "Reconciliation
        of net income (loss) attributable to Teva to Non-GAAP net income (loss) attributable to Teva" table.</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">&#167; Represents an amount of less than $0.5 million.</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td colspan="4" style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td style="max-width:23%; width:23%; min-width:23%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:11%; width:11%; min-width:11%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="17" style="text-align: center ; vertical-align: middle; "><strong>Segment Information </strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="16" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>United States</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Europe</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>International Markets </strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three
        months ended March 31,</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three
        months ended March 31,</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three
        months ended March 31,</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>(U.S. $ in millions)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>(U.S. $ in millions)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>(U.S. $ in millions)</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Revenues</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,910</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,725</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,194</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,272</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">582</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">597</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Cost of sales</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">851</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">867</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">536</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">534</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">304</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">300</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Gross profit</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">1,058</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">858</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">658</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">738</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">278</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">297</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">R&amp;D expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">154</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">154</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">60</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">56</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">25</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">S&amp;M expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">273</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">261</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">199</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">194</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">118</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">118</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">G&amp;A expenses</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">96</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">93</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">69</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">65</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">39</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">35</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">3</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#167;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">1</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(1)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#167;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Segment profit</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">532</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">350</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">329</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">423</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">97</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">117</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="6" style="text-align: left ; vertical-align: middle; ">&#167; Represents an amount less than $0.5 million.</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br > <br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="7" style="text-align: center ; vertical-align: middle; "><strong>Reconciliation of our segment profit</strong></td></tr>
  <tr>
    <td colspan="7" style="text-align: center ; vertical-align: middle; "><strong>to consolidated income (loss) before income taxes</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March 31,</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td style="max-width:64%; width:64%; min-width:64%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>(U.S.$ in millions)</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">United States profit</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">532</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">350</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Europe profit</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">329</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">423</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">International Markets profit</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">97</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">117</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Total reportable segment profit</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">958</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">890</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Profit (loss) of other activities</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(13)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">2</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">946</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">892</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Amounts not allocated to segments:</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 30.0px; ">Amortization</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">145</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">152</td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 30.0px; ">Other asset impairments, restructuring and other items</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(22)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">673</td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 30.0px; ">Intangible asset impairments</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">121</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">80</td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 30.0px; ">Legal settlements and loss contingencies</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">83</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">106</td></tr>
  <tr>
    <td style="vertical-align: middle; text-align: left; padding-left: 30.0px; ">Other unallocated amounts</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">99</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">99</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Consolidated operating income (loss)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">519</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">(218)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Financial expenses - net</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">225</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">250</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Consolidated income (loss) before income taxes</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">294</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">(467)</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br > <br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="9" style="text-align: center ; vertical-align: middle; "><strong>Segment revenues by major products and activities</strong></td></tr>
  <tr>
    <td colspan="9" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="max-width:43%; width:43%; min-width:43%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:20%; width:20%; min-width:20%;;text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March
        31,</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>Percentage Change </strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>2024-2025</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>(U.S.$ in millions)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>United States segment</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Generic products (including biosimilars)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">849</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">808</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">5%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">AJOVY</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">53</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">45</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">18%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">AUSTEDO</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">396</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">282</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">40%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">BENDEKA and TREANDA</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">36</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">46</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(20%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">COPAXONE</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">54</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">30</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">79%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">UZEDY</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">39</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">15</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">156%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Anda</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">373</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">381</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(2%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">109</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">117</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">(7%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Total</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>1,910</strong></td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>1,725</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>11%</strong></td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td class="hugin">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td>
    <td class="hugin">&#160;</td></tr>
  <tr>
    <td colspan="9" style="text-align: left ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March
        31,</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>Percentage Change </strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>2024-2025</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>(U.S.$ in millions)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Europe segment</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Generic products (including OTC and biosimilars)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">989</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">1,004</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(1%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">AJOVY</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">58</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">51</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">14%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">COPAXONE</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">42</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">57</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(27%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Respiratory products</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">55</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">66</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(18%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">50</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">94</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">(46%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Total</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>1,194</strong></td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>1,272</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>(6%)</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three months ended</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>March
        31,</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>Percentage Change </strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; "><strong>2024-2025</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>(U.S.$ in millions)</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>International Markets segment</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Generic products (including OT and biosimilars)</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">468</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: left ; vertical-align: middle; ">$</td>
    <td style="text-align: right ; vertical-align: middle; ">477</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(2%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">AJOVY</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">28</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">17</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">65%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">AUSTEDO</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">15</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">14</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">4%</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">COPAXONE</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">10</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">12</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">(11%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Other*</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">61</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">77</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">(21%)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; "><strong>Total</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>582</strong></td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; "><strong>597</strong></td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>(2%)</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td colspan="9" style="text-align: left ; vertical-align: middle; ">* Other revenues in the first quarter of 2025 include the sale of certain
        product rights.</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td></tr>
  </table>

<p><br ></p>

<table style="width:100%; border-collapse:collapse !important;;border-collapse: collapse; ">
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; "><strong>Free cash flow reconciliation</strong></td></tr>
  <tr>
    <td colspan="6" style="text-align: center ; vertical-align: middle; ">(Unaudited)</td></tr>
  <tr>
    <td style="max-width:65%; width:65%; min-width:65%;;text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:1%; width:1%; min-width:1%;;border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="max-width:16%; width:16%; min-width:16%;;border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>Three
        months ended March 31,</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2025</strong></td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td colspan="2" style="border-top: solid black 1pt ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: middle; "><strong>2024</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td colspan="5" style="text-align: center ; vertical-align: middle; "><strong>(U.S. $ in millions)</strong></td></tr>
  <tr>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: center ; vertical-align: middle; ">&#160;</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Net cash provided by (used in) operating activities</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(105)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(124)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Beneficial interest collected in exchange for securitized accounts receivables</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">322</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">295</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Capital investment</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(127)</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(124)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Acquisition of businesses, net of cash acquired</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">-</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="text-align: right ; vertical-align: middle; ">(15)</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Proceeds from divestitures of businesses and other assets, net</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">17</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-bottom: solid black 1pt ; text-align: right ; vertical-align: middle; ">-</td></tr>
  <tr>
    <td style="text-align: left ; vertical-align: middle; ">Free cash flow</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">107</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">&#160;</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: left ; vertical-align: middle; ">$</td>
    <td style="border-top: solid black 1pt ; border-bottom: double black 3pt ; text-align: right ; vertical-align: middle; ">32</td></tr>
  </table>

<p><strong>Teva Media Inquiries</strong><strong><br > </strong><strong><u>TevaCommunicationsNorthAmerica@tevapharm.com</u></strong></p>

<p><strong>Teva Investor Relations Inquires</strong><strong><br > </strong><strong><u>TevaIR@Tevapharm.com</u></strong></p>

<p>A PDF accompanying this announcement is available at&#160;http://ml-eu.globenewswire.com/Resource/Download/d4898052-9a00-4a3e-a329-e519a3693b1e</p>

<p ></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gnw-20190101.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:gnw="http://globenewswire.com/20190101" elementFormDefault="qualified" targetNamespace="http://globenewswire.com/20190101">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://globenewswire.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gnw-20190101_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>gnw-20190101_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="gnw-20190101.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaapCommonClassAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="55" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gnw-20190101_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gnw-20190101_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="no"?>
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://globenewswire.com/role/Cover" xlink:href="gnw-20190101.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://globenewswire.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 07, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  07,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-16174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TEVA PHARMACEUTICAL INDUSTRIES LIMITED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">124 Dvora Hanevi&#8217;a Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6944020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-914-8213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TEVA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  4XIUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  4XIUK:#NOM[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M8*#J<.H\-(S,\I/>4AHX-^:7,9S4F;(=X/E*2O/>L(?'XNS?_P=02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  %.*=:F5R<(Q &  "<)P  $P
M            @ '@ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M  4XIUKG-E5<2@0   <0   8              " @2$(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  %.*=:GZ ;\+$"  #B#   #0
M            @ &A#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  4XIUJ7
MBKL<P    !,"   +              "  7T/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    (  4XIUJJQ"(6,P$  "("   /              "  680  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  %.*=:)!Z;HJT   #X 0  &@
M        @ '&$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  %.*=:99!YDAD!  #/ P  $P              @ &K$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #U$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_050725.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://globenewswire.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="f8k_050725.htm">f8k_050725.htm</File>
    <File>gnw-20190101.xsd</File>
    <File>gnw-20190101_def.xml</File>
    <File>gnw-20190101_lab.xml</File>
    <File>gnw-20190101_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="21">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "f8k_050725.htm": {
   "nsprefix": "gnw",
   "nsuri": "http://globenewswire.com/20190101",
   "dts": {
    "inline": {
     "local": [
      "f8k_050725.htm"
     ]
    },
    "schema": {
     "local": [
      "gnw-20190101.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gnw-20190101_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gnw-20190101_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gnw-20190101_pre.xml"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 21
   },
   "report": {
    "R1": {
     "role": "http://globenewswire.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Form8K",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_050725.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Form8K",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f8k_050725.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://globenewswire.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001171843-25-002849-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-25-002849-xbrl.zip
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M[NCN^KUR^:^;?W$[H2'6HYS\^O[3+]?*Q^O?;W^_^7)]JIR=<7Q^CD]Z8^G
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M^(L$*7FX\5E)\N+T8CAR'NX0!Y.E%ME\Z/L@VPD>F=@ !.T1Z#0@<.[G!R[
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M'CH3I@;ZV[4IL#6, -^9L^"PKK,!'BS%05KX&]J!AT'#>UQ<@8=P\!TADV$
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MU_:3%]"O-U,M8&6+<&!VTSP^XEW2:4I;N?GGOVXN%5WSM"BI?[*4=VS@P.L
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MB*S02D*FA!4!],/2_Y$CG &S"E:MS8%>M#B:,&>([1["?9^"#!6PT@B]O+,
MS2OEEYC:()E%1U)^W@.CC];SV7@ #H4'?^6&K+ %9G7E-Z!?.,S6J-D26%F
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MP?X@@]T@32?408:%B3>"TQ =G+=%EL C?F/@0!B+CLN&Q6)*Q-#F&;]HBL!
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M.4[Y:-)@5*[0.2ZNT&%_?T=7XY"%+W[ZNWSQ(F*4X4T^7^7(7FGEHA)'=2C
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MG;SRTPG0HFCMN=^46.NV,K;6RK.U3K]:AN@GH$7-PZZ")M-<QO=X9H_.?/C
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MY+#:WUEH45FH,^LZFDM";[-VT^QG9%%AQ>.R"RQJ=P^1124)5U'/UWDLGV=
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MS3G(4H)+\#CV2O[EBZ]DH'SPQ1ARJU"91&R.TS$==P%T@B;\2?BO:@I3["S
MR>)]LG+/<[#J0$Y=$%N/5@#V%0*'Z4W6E;D'IBAP2!9S/#$<VQ''5!*'C;EG
MSE=,*UTY)^LGCLN#QAHYP=.\RVO=3L? 7)_,!'@R@[.MJ8#54;&:@ROO]#)!
MBM5P^5T*;>F P5P?VKQ5O]T-NGIK"V-VY&*LQF4BC]G5O5QMZ5[V5L8W^=IX
MB_?@;DZN*_*UZ7L*CL9<:!; T3Q?MPZA9!H*^(IF?+Q6R74[8>Y.H8HU+7>!
MQ%\YD$9#>!#)L"(83.WP';@O]6R<4:BMMT41&.^T.E0XTDSWSJ:^I79"D[XE
M[9<EDB@^V'C?9^->=6[UJR>7=E;NZ:2P!W3"BB/!Z-?BB('X8%#JOM*%W'>3
M*8,8<Q5NJ/04FYG-GIC>QOM(!LL-F,WW)BW\D%1+E6J)])D,7:4W;)\")J*N
M%Y1,/B7Z[_C@#[@ L1IA6!<QAUK0>O)(ZJC^C S9"R7/4!-GU&:AKO4$\EX(
M6#&#W"NG!)D-9@&'4!+HG60!_D7!IZCG@1/8>@<)^%UZAX@D0*]"<T=.9ISO
M@0JHSS7+,% B;7"\(-DKRE* I#0.A<?E%,EC/IOR$5>DT2A9Z%PZ;75"(7!,
MB*Y(X.E4O+^%2D.LW$LN$>L\0'4>QB3.\+ ;M[_B\S%X'[V&2$NN6Y9B:V,N
M: U74)JM5I/9-4N)-1'WB*&&EG)HOC-I&ME,0B)URH;OY10RG8[D$8,* @G"
M(7@N5*U<C[G+'/VS=:UU#7$'W1#3KI/$W=6>=>$,%4QGQD@G^$%$)@T<43L]
M XY$Q!M/LY919%J#J!M,*=$.XL8MI*CTI;DY(_[Z5'>&O2P+S-4%S<<(,YSV
M']RT9 I5 GD,F(BN-MA9;F0(?D@CADS-2]_F.S!V&Z6*54I%J#Z0Q?$U-J_V
M7'EPO)XXI\G'ZWNFZSN@AUV2V-I-;MKZ=Y@=G20WC1WQOCZ0?M%E\+9@\B24
M]RA:'_W2SLXU'K0JP3R56W=\]*T,WC%I"Q[$^]CQU:?,(+2-@;T9?8MT6;B]
MN+FAQ-PI9_/I[XV&59HJD!*3Y4V9[IX>WL9E/E%=5DQ&ECK10V@(J<@_0WVI
M*!4H4;E;<KB7J%:E_@?)T_%AYB7/T!Y '016J:W/2>^HHN;:PPF;C9B#61+[
M))WR$11]C.!OK1 G\J.\/:9TAMEZP_FOT/$,()JH"L5!YUO;[A4->C\]MH=?
M^MON-5?6;G.:#OB_(1=1PMVWX.6TSDX(Q<.FH=3] 9?1S4HD _5%@@2PX)L+
M<B,&=6>,!081Z403 6 ' >VQ;]#14$U] =P[I>VG7D>_XO;V1(KS$I*';'G
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MX^Q*Z:4T ;=4N\5SN^0G35"UNQ;6!TM/LRSG=B]4L2=%DZ4'?O#=)_H#G4W
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MND4#,MIF0U<%! =@#:"C4J/%?.9S)EGB_3P6H"9/2?D\> \EH-XM+#VVV\P
MXH#0Z78($"2"4#O*)TAS&C&^98W''69L)P; PXS%\ JE)\HM5(.:T$:K,R0@
MP(;X!#!KA7XJGTE!C*.J B1K\$+<51R+ Y55_]TFE)R"[;=JW=+58;?-E$48
M$$FP.X"?2OE)?4 R!MW34*"9OJ.I4__03(=",PT:FNE'H%F^L4"@.7M'4\_\
M0W,V%)JSH*$Y^Q THN.]CC4S\?&>+]F;[>%L4.D%&=.J%9BC+#Q<#&]]L,@
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MA+\+'DN()X1 \P!(ACY$G""3O5"5@3[96I!H)^;'P^ETM4SRU'9R:4J<S4F
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MRE.S0?.Q5&ZCV<7#950)@=M4R".[-@)M0BB :QI=)/*U&U-FP/<']D/'?BA
MF'^^%1NZG>E,D2C;K8F3&>7%^K\9S9&DVT!4.Q)3LT9W4%7%<4R'F;M544NJ
MF"K#>K<NHJ)*OD[WT*VBNR3*K*@3+1C?IWJN9.JCLR4A/8$>@C*;:(;FK=E^
M;&,8<9*X<1Y)@#Q[&$"=;K"(?J0Z4FQIN=2 K2B!?/NH?!W>&L:\.W:>:<)L
MO#:4B:%$[<)PO^!I @0_P.PI@FZ1,G K1$[X,UU*50.^J@3R_AF3M\L;$N8_
M<Z(RJO@&0OI$#(3]"R9LCT,DWE-%A&:6#P3XJ1I(_%?4"P^/1R3DDP7E?"C3
M)1&@O=RE!V)_AXG=[_,-@+]_M>=W<VJ!LS]H L3_VUO!?^(6*0-/5#$9FU.Z
M K _$0.I7V%2]SA$Y7TO8BCMO11<_^##/K*'A'K$=$1X&='(+--AW XY%#E*
MS5EK$Q7[OY0H,/0#,10Y2AE:8[%AX,-<J4HPP5[%KX8B1RE ZTPVS/Q>9"S;
MC!BG7_)T]OW&:97UJ0K*&*7H])E"8;N[TR"R+R3U[,MN)90Q2JT9,H?">6C\
M*,+'(J;K3W03 GTBA9)&J3&#]E!0/RF6$K69L*B^TSC50F&C5)9A@RBTIV0]
MCHTK-F?E4\%ZZ-XF4/8H927(+DH*QB*2:BD/;A</96Z.Q\U0QL$NO:8A-!TH
M]>89UE&2<AO'!I?>_GE@@O9"J7#*P<^(\!(0L/E&L/?/P]Z'8T>I0VMMOA'L
M@_.P#^#846K16IN8V(?FXZ.:RI7G";17#$6.4HO66,0$7IQI'M63DJ^L'!Q5
M1_VD!10]8HD:-HNZPY<G><C>OE-">2.6JVYSF)R?I,X(_X\MZZXDW7HH<\3"
M-62TZ1N,9=[M30O?4*(C"90O2JWJM-,T4IMA18E_]ZTJH$!1"E"7F89Y/DC[
M[&,A1?!^[*D*RA6EDO29:KKCM:.)M??0/_@:/((-I5L]MM$PQJ^*92:"H4S3
M7&SOT7B>BGFD4+PHY5_07L.H)Y*SB&5,))_-%:)BA+LYNW10R"C%GM]8PX2?
M%+69IN:RNQC'9:<;J,?YW-?SAO10XBBU7KU17/)CK7.JSN7O: 7- DK9!S7=
M=#]#H]QT>YM>?S:U,V8\O<R)"LH:I>3SF6J8[1<Y5<1.9IMLTIGD_NDA3B&4
M,$J!%[#6,.1*'&Z\1Q(H6)3*SFD'J4^X7T<+(A+J'[W@5D(!HU1Z(7-H?6\"
MZGN3,_M>E(K/9PJ);3DVW!Q1CS/.$N*?219L )YG@TD\8+7I^7O%E)^QF$N5
M%G&,S <W=H\4"AQGBF3(7M.H\YAE-"Y#&C%!1&1*JOV\-D]U7M\*F@"<.91
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M^1]02P$"% ,4    "  %.*=:[[Q3&I%O  !!(P4 "P              @ $
M    97AH7SDY,2YH=&U02P$"% ,4    "  %.*=:\!_6^-0-  "*.P  #@
M            @ &Z;P  9CAK7S U,#<R-2YH=&U02P$"% ,4    "  %.*=:
MA257J[ "  #5"P  $               @ &Z?0  9VYW+3(P,3DP,3 Q+GAS
M9%!+ 0(4 Q0    (  4XIUJO[VJ!40@  (=D   4              "  9B
M  !G;G<M,C Q.3 Q,#%?9&5F+GAM;%!+ 0(4 Q0    (  4XIUIG4='PE@H
M )B%   4              "  1N)  !G;G<M,C Q.3 Q,#%?;&%B+GAM;%!+
M 0(4 Q0    (  4XIUILP4#5]P8  /96   4              "  >.3  !G
I;G<M,C Q.3 Q,#%?<')E+GAM;%!+!08     !@ & 'D!   ,FP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>f8k_050725_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gnw-20190101.xsd" xlink:type="simple"/>
    <context id="Form8K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818686</identifier>
        </entity>
        <period>
            <startDate>2025-05-07</startDate>
            <endDate>2025-05-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="Form8K" id="ixv-139">0000818686</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="Form8K" id="ixv-140">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="Form8K" id="ixv-160">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="Form8K" id="ixv-161">2025-05-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="Form8K" id="ixv-162">TEVA PHARMACEUTICAL INDUSTRIES LIMITED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="Form8K" id="ixv-163">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="Form8K" id="ixv-164">001-16174</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="Form8K" id="ixv-165">124 Dvora Hanevi&#x2019;a Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="Form8K" id="ixv-166">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="Form8K" id="ixv-167">6944020</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="Form8K" id="ixv-168">IL</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="Form8K" id="ixv-169">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="Form8K" id="ixv-170">3-914-8213</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="Form8K" id="ixv-171">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="Form8K" id="ixv-172">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="Form8K" id="ixv-173">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="Form8K" id="ixv-174">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="Form8K" id="ixv-175">American Depositary Shares, each representing one Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="Form8K" id="ixv-176">TEVA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="Form8K" id="ixv-177">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="Form8K" id="ixv-178">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
